Share this post on:

Man DR, White JG, Keely PJ: Collagen reorganization at the tumor-stromal interface facilitates neighborhood invasion. BMC Med 2006, four:38. 27. Ng MR, Brugge JS: A stiff blow from the stroma: collagen crosslinking drives tumor progression. Cancer Cell 2009, 16:45557. 28. Provenzano PP, Inman DR, Eliceiri KW, Keely PJ: Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression via a FAK-ERK linkage. Oncogene 2009, 28:4326343. 29. Santala M, Simojoki M, Risteli J, Risteli L, Kauppila A: Kind I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer. Clin Cancer Res 1999, five:4091096. 30. Maurer B, Stanczyk J, Jungel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O: MicroRNA-29, a crucial regulator of collagen expression in systemic sclerosis. Arthritis Rheum 2010, 62:1733743. 31. Rothschild SI, Tschan MP, Federzoni EA, Jaggi R, Fey MF, Gugger M, Gautschi O: MicroRNA-29b is involved inside the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma. Oncogene 2012, 31:4221232. 32. Qian BZ, Pollard JW: Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:391. 33. Santoni M, Massari F, Amantini C, Nabissi M, Maines F, Burattini L, Berardi R, Santoni G, Montironi R, Tortora G, Cascinu S: Emerging role of tumor-associated macrophages as therapeutic targets in individuals with metastatic renal cell carcinoma. Cancer Immunol Immunother 2013, 62:1757768. 34. Hwang TL, Lee LY, Wang CC, Liang Y, Huang SF, Wu CM: CCL7 and CCL21 overexpression in gastric cancer is related to lymph node metastasis and poor prognosis. World J Gastroenterol 2012, 18:1249256. 35. Okada M, Saio M, Kito Y, Ohe N, Yano H, Yoshimura S, Iwama T, Takami T: Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1. Int J Oncol 2009, 34:1621627. 36. Wyler L, Napoli CU, Ingold B, Sulser T, Heikenwalder M, Schraml P, Moch H: Brain metastasis in renal cancer sufferers: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. Br J Cancer 2014, 110:68694.37. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW: CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011, 475:22225. 38. Hemmerlein B, Johanns U, Kugler A, Reffelmann M, Radzun HJ: Quantification and in situ localization of MCP-1 mRNA and its relation to the immune response of renal cell carcinoma. Cytokine 2001, 13:22733. 39. Jung DW, Che ZM, Kim J, Kim K, Kim KY, Williams D, Kim J: Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal function of CCL7.Lasalocid Epigenetics Int J Cancer 2010, 127:33244.DCVC Protocol 40.PMID:24456950 Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, St kel S, van den Berg E, Zbar B: The Heidelberg classification of renal cell tumours. J Pathol 1997, 183:13133. 41. Pichler M, Hutterer GC, Chromecki TF, Jesche J, Kampel-Kettner K, Groselj-Strele A, Hoefler G, Pummer K, Zigeuner R: Comparison with the 2002 and TNM classification systems with regards to outcome prediction in clear cell and papillary renal cell carcinoma. Histopathology 2010, 2013(62):23746. 42. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, six:65563. 43. Si.

Share this post on: